Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.
- DOI
- 10.1186/s12874-025-02500-w
- Published
- 2025 Mar 1
- Container
- BMC medical research methodology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12874-025-02500-w,
title = {Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.},
author = {Esnault C and Baschet L and Barbet V and Chenuc G and Pérol M and Thokagevistk K and Pau D and Monnereau M and Bosquet L and Filleron T},
year = {2025},
journal = {BMC medical research methodology},
doi = {10.1186/s12874-025-02500-w},
url = {https://doi.org/10.1186/s12874-025-02500-w}
}RIS
TY - JOUR TI - Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer. AU - Esnault C AU - Baschet L AU - Barbet V AU - Chenuc G AU - Pérol M AU - Thokagevistk K AU - Pau D AU - Monnereau M AU - Bosquet L AU - Filleron T PY - 2025 JO - BMC medical research methodology DO - 10.1186/s12874-025-02500-w UR - https://doi.org/10.1186/s12874-025-02500-w ER -
APA
C, E., L, B., V, B., G, C., M, P., K, T., D, P., M, M., L, B., & T, F. (2025). Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer.. BMC medical research methodology. https://doi.org/10.1186/s12874-025-02500-w
Source records
- pubmed · retrieved 2026-09-25T19:38:32.426Z